Loading...
Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line
Glioblastoma Multiforme (GBM) is the most common of malignant gliomas in adults with an exiguous life expectancy. Standard treatments are not curative and the resistance to both chemotherapy and conventional radiotherapy (RT) plans is the main cause of GBM care failures. Proton therapy (PT) shows a...
Saved in:
| Published in: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6801826/ https://ncbi.nlm.nih.gov/pubmed/31554327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20194745 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|